Absci · pitchdeck
Absci | IPO Presentation Deck | 65 slides
65 pages · 0 arc beats · 0 loops
Absci | IPO Presentation Deck | 65 slides
Absci · 2021-07 arc beats above · slides in the middle · loops below · scroll → 0 LOOPS
15101520253035404550556065
Deck intelligence map
1 coverage by narrative range · generated from this deck JSON
Narrative range 65 total
Metadata
Components
Metrics
Tools
Frameworks
Beats
Loops
Whole deck 65 slides 100% 65/65 slides 100% 65/65 slides · 276 hits — 0/65 slides
66.2% 43/65 slides · 48 hits 50.8% 33/65 slides — 0/65 slides
— 0/65 slides
Slide inventory
65 every slide · same image gating as the playbook
06
The slide uses a horizontal timeline-like structure to categorize key business pillars.summarize
10
The slide uses a minimalist icon-based layout to highlight two core proprietary technologies.present_solution
11
The slide uses a three-column layout to define the company's core technological pillars.present_solution
12
The slide uses a consistent icon-grid layout to present four distinct technological capabilities.present_solution
13
The slide uses a series of five distinct colored cards, each representing a core technology component with an icon and a descriptive paragraph.present_solution
14
The slide uses a modular icon-grid layout to present the company's core technology stack.present_solution
15
The slide uses a rhetorical question to bridge the gap between the mission statement and the solution/technology section.transition
16
The slide uses a linear process flow to represent the time-intensive nature of conventional drug development.establish_context
17
The slide uses a process flow diagram to identify a bottleneck in the traditional drug development pipeline.frame_problem
18
The slide uses a process flow to identify a bottleneck/failure point in standard industry practices.frame_problem
19
Uses a process flow diagram to contrast the standard R&D pipeline with three specific industry pain points.frame_problem
20
The slide uses a 'What if' framing to establish a high-level vision for the company.inspire_vision
21
The slide contrasts a traditional sequential process (implied by the 'Years' label) with an integrated approach (implied by 'Weeks or Months').present_solution
22
The slide contrasts a traditional multi-step process (implied by the left-hand list) with an integrated approach that collapses the timeline from years to weekspresent_solution
23
The slide uses a process flow diagram on the left and an icon-based illustration of various protein modalities on the right.present_solution
24
The slide uses a large, stylized question mark to signify the 'problem' or 'question' being addressed by the company.frame_problem
25
The slide uses a bracket-style diagram to segment competitors by industry focus.compare_peers
26
The slide uses a continuous line path to group companies into 'Synthetic Biology' (sub-segments: Other industries, Biopharma) and 'AI Enabled Drug Discovery' (scompare_peers
27
The slide uses a custom flow-chart/diagram style to group competitors by technology category.compare_peers
28
The slide uses a continuous line diagram to connect Absci's presence across multiple industry segments compared to other players.compare_peers
29
The slide uses a stylized red icon of a cell or protein structure to reinforce the biotech theme.inspire_vision
30
The slide uses a linear process flow to represent the company's integrated technology stack.present_solution
31
The slide uses a process diagram to contrast a traditional linear drug discovery workflow with their proprietary integrated platform.present_solution
32
This appears to be the first slide in a multi-part sequence explaining the platform process.present_solution
33
This appears to be the first slide of a multi-part process diagram.present_solution
34
The slide uses a linear process flow to explain the company's core technology platform.present_solution
35
The slide uses a linear process flow to describe the platform's capabilities.present_solution
36
The slide uses a linear process diagram to explain the proprietary platform workflow.present_solution
37
The slide uses a linear process flow to explain the end-to-end drug creation workflow.present_solution
38
The slide uses a linear process flow to explain the proprietary drug discovery pipeline.present_solution
39
The slide highlights the integration of Totient's workflow into the drug discovery process.illustrate_case
40
The slide uses a linear process flow to demonstrate speed (5 days + 10 days).illustrate_case
41
Uses a process flow framework to demonstrate speed of drug discovery.illustrate_case
42
The slide uses a continuous line graphic to connect the applications, suggesting a workflow or integrated platform.present_solution
43
The slide uses a metaphorical 'new letter in your alphabet' to describe the expansion of the genetic code.present_solution
44
The slide uses a continuous line graphic to connect different stages of the drug development process.present_solution
45
The slide uses a process flow framework to visualize the company's proprietary platform.present_solution
46
The slide uses a circular process flow with an AI feedback loop at the bottom.present_solution
47
The slide uses a circular process flow with an AI core, highlighting specific parameters for drug and cell line design.present_solution
48
The central image is a visualization of a complex molecular structure, likely representing the protein sequence space.present_solution
49
The slide uses a 'What if' framing to establish a vision for the company's technology.inspire_vision
50
The slide uses a circular flow diagram connecting 'Predict' and 'Learn' phases via an AI engine, culminating in drug creation.present_solution
51
The slide uses a high-level, aspirational statement to define the company's mission/vision.inspire_vision
52
The slide uses a linear process flow to map financial milestones to development stages.present_framework
53
The diagram uses a series of nested 'L' shapes to show that the platform can be engaged at any point in the drug development lifecycle, with cumulative value represent_solution
54
The chart segments biologics into 'Other' and 'Next-Generation' across six development stages.size_opportunity
55
The slide uses an icon grid to represent different biological drug formats.present_solution
56
The diagram illustrates a network or hierarchy of molecule types, though it functions primarily as a visual list of capabilities.show_traction
57
The slide uses a stylized, continuous line graphic to represent the progression of the partnership.plan_implementation
58
The slide uses a hub-and-spoke diagram to illustrate the versatility of the company's protein platform.inspire_vision
59
Uses a stylized line graphic that incorporates icons of scientists/lab work.transition
61
The slide uses a visual metaphor of a lightbulb connected to the 'Join us' text, suggesting innovation and collaboration.state_next_steps
64
The slide uses a funnel-like process flow to show the reduction of variants from billions to tens.present_solution
65
The slide uses a process flow diagram to show the transition from input sequences to functional embedding, homology search, and experimental validation.illustrate_case